Arya pharmaceutical company has been producing pharmaceutical products for many years. During these years, various products have been produced and various technologies have been used in their production. Arya Pharmaceuticals has always tried to use new production methods and raw materials of the day. It may be strange for you to hear that in a situation where limited materials such as starch, lactose, and gum Arabic were the basis of pharmaceutical formulations, the use of materials such as microcrystalline cellulose, PVP, cross-Carmel lose, silicon dioxide, odergeite, etc. was a new and original work. The rapid spread of these materials has forgotten the pioneers of its use. Also, the use of advanced tools and facilities in different stages of granulation, pressing, coating and introducing new drug delivery systems into the production methods made Arya Pharmaceutical Company a leading company in the pharmaceutical industry. For this reason, products from Arya Pharmaceuticals have been welcomed by consumers and have gained many fans.

Today, the preservation and protection of the achievements of several years of active presence in the pharmaceutical industry is the responsibility of pharmaceutical science experts who are working in different departments of the company, especially the responsibility of the research department of the company is heavier and more important.
Therefore, it is necessary that this department, by having an internal publication, can expand the scope of discussion about current issues and internal issues of the company and use the opinions and scientific ability of all colleagues in other departments of the company to improve its scientific ability. Due to the importance of the topic and the need to focus on the content and issues surrounding 5-Amniosalicylic Acid (Mesalazine), the content of this issue of the publication is dedicated to this product.